Genetically modified cell implant comprising an exogenous nucleotide sequence coding for all or part of an antibody, method for the preparation of such an implant and its therapeutic use for the treatment or prevention of an acquired disease. The invention also concerns an adenoviral vector, a pharmaceutical composition and its therapeutic use.

 
Web www.patentalert.com

< Methods for lyophilizing competent cells

< Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability

> Exendins, exendin agonists, and methods for their use

> Iron chelator delivery system
~ 00217